These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

349 related items for PubMed ID: 9774378

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Blood pressure-lowering effect of an orally active vasopressin V1 receptor antagonist in mineralocorticoid hypertension in the rat.
    Burrell LM, Phillips PA, Stephenson JM, Risvanis J, Rolls KA, Johnston CI.
    Hypertension; 1994 Jun; 23(6 Pt 1):737-43. PubMed ID: 8206571
    [Abstract] [Full Text] [Related]

  • 3. Blood pressure and small arteries in DOCA-salt-treated genetically AVP-deficient rats: role of endothelin.
    Intengan HD, Park JB, Schiffrin EL.
    Hypertension; 1999 Oct; 34(4 Pt 2):907-13. PubMed ID: 10523383
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Magnesium supplementation and deoxycorticosterone acetate--salt hypertension: effect on arterial mechanical properties and on activity of endothelin-1.
    Berthon N, Laurant P, Hayoz D, Fellmann D, Brunner HR, Berthelot A.
    Can J Physiol Pharmacol; 2002 Jun; 80(6):553-61. PubMed ID: 12117304
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Endothelin receptor function in mesenteric veins from deoxycorticosterone acetate salt-hypertensive rats.
    Johnson RJ, Fink GD, Watts SW, Galligan JJ.
    J Hypertens; 2002 Apr; 20(4):665-76. PubMed ID: 11910302
    [Abstract] [Full Text] [Related]

  • 8. Endothelin-1 gene expression and vascular hypertrophy in DOCA-salt hypertension compared to spontaneously hypertensive rats.
    Schiffrin EL, Lariviere R, Li JS, Sventek P, Touyz RM.
    Clin Exp Pharmacol Physiol Suppl; 1995 Dec; 22(1):S188-90. PubMed ID: 9072349
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Mechanical properties of mesenteric resistance arteries from Dahl salt-resistant and salt-sensitive rats: role of endothelin-1.
    Intengan HD, Schiffrin EL.
    J Hypertens; 1998 Dec; 16(12 Pt 2):1907-12. PubMed ID: 9886876
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Ovarian hormones modulate endothelin-1 vascular reactivity and mRNA expression in DOCA-salt hypertensive rats.
    David FL, Carvalho MH, Cobra AL, Nigro D, Fortes ZB, Rebouças NA, Tostes RC.
    Hypertension; 2001 Sep; 38(3 Pt 2):692-6. PubMed ID: 11566958
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Different contributions of endothelin-A and endothelin-B receptors in the pathogenesis of deoxycorticosterone acetate-salt-induced hypertension in rats.
    Matsumura Y, Hashimoto N, Taira S, Kuro T, Kitano R, Ohkita M, Opgenorth TJ, Takaoka M.
    Hypertension; 1999 Feb; 33(2):759-65. PubMed ID: 10024341
    [Abstract] [Full Text] [Related]

  • 16. Coronary vascular reactivity is improved by endothelin A receptor blockade in DOCA-salt hypertensive rats.
    Giulumian AD, Pollock DM, Clarke N, Fuchs LC.
    Am J Physiol; 1998 Jun; 274(6):R1613-8. PubMed ID: 9608015
    [Abstract] [Full Text] [Related]

  • 17. Effect of antihypertensive treatment and N omega-nitro-L-arginine methyl ester on cardiovascular structure in deoxycorticosterone acetate-salt hypertensive rats.
    Li JS, Sventek P, Schiffrin EL.
    J Hypertens; 1996 Nov; 14(11):1331-9. PubMed ID: 8934362
    [Abstract] [Full Text] [Related]

  • 18. Increased expression of endothelin-1 gene in blood vessels of deoxycorticosterone acetate-salt hypertensive rats.
    Larivière R, Day R, Schiffrin EL.
    Hypertension; 1993 Jun; 21(6 Pt 2):916-20. PubMed ID: 8505101
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Endothelin-1 expression in blood vessels of DOCA-salt hypertensive rats treated with the combined ETA/ETB endothelin receptor antagonist bosentan.
    Larivière R, Sventek P, Thibault G, Schiffrin EL.
    Can J Physiol Pharmacol; 1995 Mar; 73(3):390-8. PubMed ID: 7544236
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.